New Zealand Venture Investment Fund logo

New Zealand Venture Investment Fund

Oceania, Auckland, New Zealand, Auckland

Description

New Zealand Venture Investment Fund, a New Zealand-based private equity fund, manages fund of funds investments and direct co-investments.

Investor Profile

New Zealand Venture Investment Fund has made 9 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (22%)
  • Series A (22%)
  • Convertible Note (22%)
  • Series B (11%)
  • Angel (11%)
  • Series Unknown (11%)

Country Focus

  • New Zealand (67%)
  • United States (22%)
  • The Netherlands (11%)

Industry Focus

  • Software
  • Apps
  • Edtech
  • Education
  • Higher Education
  • Primary Education
  • Productivity Tools
  • Secondary Education
  • Audio
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does New Zealand Venture Investment Fund frequently co-invest with?

EI
Oceania, Auckland, New Zealand, Auckland
Co-Investments: 1
East Ventures
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Prelude Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Enterprise Angels
Oceania, Gisborne, New Zealand, Tauranga
Co-Investments: 1
Flying Kiwi Angels
Oceania, Auckland, New Zealand, Auckland
Co-Investments: 2
Ice Angels
Oceania, Auckland, New Zealand, Auckland
Co-Investments: 1
Sparkbox Ventures
Oceania, Auckland, New Zealand, Auckland
Co-Investments: 2
DCVC
North America, California, United States, San Francisco
Co-Investments: 1
K1W1
Oceania, Auckland, New Zealand, Auckland
Co-Investments: 2
IDATEN Ventures
Asia, Chiba, Japan, Minato
Co-Investments: 1

Which angels does New Zealand Venture Investment Fund often collaborate with?

AV
North America, California, United States
Shared Deals: 1
Allan Moss
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1
Chris Sang
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1
SA
North America, California, United States, San Francisco
Shared Deals: 1
SN
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by New Zealand Venture Investment Fund?

Surgical Design Studios

Parnell, Auckland, New Zealand

Surgical Design Studios is a medical device company.

Medical Device
AngelAug 1, 2019
Amount Raised: $4,300,000
Invert Robotics

Breda, Noord-Brabant, The Netherlands

Invert Robotics is a world leading inspection solutions.

IndustrialIndustrial AutomationRobotics
Series AMay 2, 2019
Amount Raised: $8,800,000
Nyriad

Austin, Texas, United States

Nyriad is developing the industry's first storage solutions based on a new architecture that redefines how data is stored.

ComputerData StorageFlash StorageSoftware
Series AFeb 6, 2018
Amount Raised: $8,500,000
Dotterel Technologies

Parnell, Auckland, New Zealand

Dotterel Technologies is a company that develops noise reduction and audio recording technology for UAVs.

AudioDrones
Convertible NoteAug 1, 2017
Amount Raised: $408,392
Postr

Wellington, Wellington, New Zealand

Postr is an Android app that brings personalised and rewarding content to users.

AdvertisingAppsInternetMobile Apps
Series UnknownJan 16, 2017
Amount Raised: $2,129,895
Kami

Auckland, Auckland, New Zealand

Kami is a digital learning platform that empowers everyone to #lovelearning.

AppsEdTechEducationHigher EducationPrimary EducationProductivity ToolsSecondary EducationSoftware
SeedOct 21, 2016
Kami

Auckland, Auckland, New Zealand

Kami is a digital learning platform that empowers everyone to #lovelearning.

AppsEdTechEducationHigher EducationPrimary EducationProductivity ToolsSecondary EducationSoftware
SeedFeb 17, 2015
Booktrack

Takapuna, Auckland, New Zealand

Booktrack is an artificial intelligence soundtrack company.

Artificial Intelligence (AI)AudioAudiobooksEdTechEducationMachine LearningMusicNatural Language ProcessingSoftware
Convertible NoteDec 18, 2012
Amount Raised: $2,000,000
Proacta

La Jolla, California, United States

Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated “prodrugs” for the treatment of cancer.

BiotechnologyHealth CareMedical Device
Series BFeb 7, 2007
Amount Raised: $35,000,000